FDA expands use of Pfizer drug for rare form of lung cancer

Friday, March 11, 2016 - 13:50 in Health & Medicine

WASHINGTON (AP) -- The Food and Drug Administration expanded approval of a Pfizer drug to treat a small subset of lung cancer patients with a rare mutation....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net